SyqeAir Inhaler
Commercial- Indications
- Chronic neuropathic pain, PTSD
Company intelligence / Profile preview
Syqe Medical
Tel Aviv, Israelsyqe.com ↗
- Ownership
- Private
- Employees
- ~116
- Development stage
- Commercial
01
Overview
Clinical trials demonstrate rapid pain reduction with minimal psychoactive effects; 92% of patients report improved quality of life; supported by real-world evidence and patient testimonials.
- Therapeutic areas
- Neurology
- Modalities
- DevicePlant-derived small molecule delivery system
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Teva Pharmaceuticals (marketing/distribution)Ministry of Defense (Israel) (cooperation agreement)Meuhedet HMO (cooperation agreement)
Beyond the preview
Go deeper on Syqe Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Syqe Medical.